| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999460 | Urologic Oncology: Seminars and Original Investigations | 2015 | 7 Pages |
Abstract
PSC appears to be a prognostic factor in patients with sRCC, with larger percentage of involvement portending a worse survival, especially in patients with metastatic disease.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Mehrad M.D., Arun Z. M.D., Leonardo D. M.D., Megan M. D.O., Rebecca S. M.S., Hsiang-Chun M.S., Kanishka M.D., Paari M.D., Pheroze M.D., Eric M.D., Nizar M. M.D., F.A.C.P., Surena F. M.D., F.A.C.S., Christopher G. M.D., F.A.C.S., Jose A. M.D., F.A.C.S.,